Enrichment
Enrichment
批准号:
10589762
负责人:
Kari N Nejak-Bowen
金额:
$3.68万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2024-03-31
关键词:
Academic skillsAddressAdvanced DevelopmentAwardBasic ScienceChildhoodCholestasisClinicClinical ResearchCollaborationsCommunitiesDedicationsDiseaseEducationEducation and OutreachEducational workshopExhibitsExtramural ActivitiesFacultyFeedbackFibrosisFocus GroupsFosteringFundingFutureGoalsHealthInformation DisseminationInstitutionInstructionJointsKnowledgeLiverMedical centerMedicineMissionOrganization and AdministrationPathologyPatient CarePediatric HospitalsPediatricsPhysiciansPostdoctoral FellowProgress ReportsResearchResearch PersonnelResourcesScienceScientistSeriesTraining ActivityTranslational ResearchUniversitiesVisitWorkbasebench to bedsidecareercareer developmentgraduate studentimprovedinnovationinterdisciplinary approachmemberprogramsskill acquisitionspecial interest groupsuccess
中文摘要
根据RFA-DK-18-001说明,只需要一份摘要/摘要
应用程序的组件。此组件中不包含任何摘要。
英文摘要
Per the RFA-DK-18-001 instructions, an Abstract/Summary was only required for the Overall
Component of the application. No abstract is included in this component.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
-
批准号:10478241
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2020
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
-
批准号:10673971
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2020
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
-
批准号:10119767
-
项目类别:
-
资助金额:$46.21万
-
财政年份:2020
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
-
批准号:10264151
-
项目类别:
-
资助金额:$43.52万
-
财政年份:2020
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Enrichment
-
批准号:10372009
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2019
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Enrichment
-
批准号:10117241
-
项目类别:
-
资助金额:$3.68万
-
财政年份:2019
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Beta-catenin-driven hepatobiliary reprogramming as a therapeutic modality for cholangiopathies
-
批准号:10409817
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2019
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Beta-catenin-driven hepatobiliary reprogramming as a therapeutic modality for cholangiopathies
-
批准号:10180952
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2019
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Beta-catenin-driven hepatobiliary reprogramming as a therapeutic modality for cholangiopathies
-
批准号:10618307
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2019
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Beta-catenin-driven hepatobiliary reprogramming as a therapeutic modality for cholangiopathies
-
批准号:10019522
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2019
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Role and regulation of beta-catenin in cholestatic liver disease
-
批准号:8959948
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2015
-
负责人:Kari N Nejak-Bowen
-
依托单位:
Role and regulation of beta-catenin in cholestatic liver disease
-
批准号:9086348
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2015
-
负责人:Kari N Nejak-Bowen
-
依托单位:
海外基金